Emily Mao

479 total citations
4 papers, 366 citations indexed

About

Emily Mao is a scholar working on Epidemiology, Oncology and Hepatology. According to data from OpenAlex, Emily Mao has authored 4 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 2 papers in Oncology and 1 paper in Hepatology. Recurrent topics in Emily Mao's work include Cancer Immunotherapy and Biomarkers (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Emily Mao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Emily Mao collaborates with scholars based in United States. Emily Mao's co-authors include Adi Diab, Phillip Lum, Hamzah Abu‐Sbeih, Yinghong Wang, Gottumukkala S. Raju, Gladis Shuttlesworth, Wei Qiao, John Stroehlein, Noman Ali and Faisal S. Ali and has published in prestigious journals such as Journal of Hepatology, Inflammatory Bowel Diseases and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Emily Mao

4 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Mao United States	3	329	128	90	36	32	4	366
Dana Alsaadi United States	4	319 1.0×	127 1.0×	106 1.2×	31 0.9×	29 0.9×	6	389
Kara M. De Felice United States	6	217 0.7×	100 0.8×	93 1.0×	46 1.3×	56 1.8×	8	326
Rashmi Samdani United States	6	273 0.8×	121 0.9×	56 0.6×	63 1.8×	36 1.1×	17	360
Jolanda van Dieren Netherlands	6	227 0.7×	81 0.6×	52 0.6×	86 2.4×	23 0.7×	11	307
Hajir Ibraheim United Kingdom	8	129 0.4×	102 0.8×	68 0.8×	17 0.5×	87 2.7×	26	259
Michael M. Feely United States	5	144 0.4×	72 0.6×	37 0.4×	32 0.9×	20 0.6×	8	203
Joselyn Sanchez Peru	8	187 0.6×	27 0.2×	63 0.7×	41 1.1×	7 0.2×	14	269
Cristina Nichita Switzerland	6	53 0.2×	100 0.8×	42 0.5×	23 0.6×	108 3.4×	13	200
Pierre‐Louis Carron France	7	103 0.3×	121 0.9×	94 1.0×	30 0.8×	16 0.5×	11	268
Ally Speight United Kingdom	7	63 0.2×	50 0.4×	31 0.3×	14 0.4×	45 1.4×	14	179

Countries citing papers authored by Emily Mao

Since Specialization

Citations

This map shows the geographic impact of Emily Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Mao more than expected).

Fields of papers citing papers by Emily Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Mao. The network helps show where Emily Mao may publish in the future.

Co-authorship network of co-authors of Emily Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Mao. A scholar is included among the top collaborators of Emily Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Mao. Emily Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Miller, E., Lara Dakhoul, Emily Mao, et al.. (2018). Increasing trend for Hepatocellular Carcinoma (HCC) linked to Nonalcoholic Fatty Liver Disease (NAFLD) in the United States. Journal of Hepatology. 68. S822–S822. 2 indexed citations

2.

Wang, Yinghong, Hamzah Abu‐Sbeih, Emily Mao, et al.. (2018). Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson. Journal for ImmunoTherapy of Cancer. 6(1). 37–37. 184 indexed citations

3.

Wang, Yinghong, Hamzah Abu‐Sbeih, Emily Mao, et al.. (2018). Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis. Inflammatory Bowel Diseases. 24(8). 1695–1705. 178 indexed citations

4.

deLemos, Andrew S., Lara Dakhoul, Patrick C. Roche, et al.. (2018). Nonalcoholic fatty liver disease is the most common cause of hepatocellular carcinoma (HCC) in individuals without cirrhosis: A United States multicenter study. Journal of Hepatology. 68. S419–S420. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact